Medifast, Inc. MED
Set alert
12.53 USD +0.38 +3.13%
At close · Nov 2
12.53 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
12.25 Day range 12.58
9.22 52-week range 13.45
- YTD
- +17.32%
- 1 year
- +4.24%
- Open
- 12.36
- Prev close
- 12.15
- Mkt cap
- 140.12M
- Vol
- 93.65K
- Avg vol
- 143.63K
- EPS
- -3.70
- P/E
- 0.00
- Div yield
- 34.41%
More statistics
- Low
- 12.25
- High
- 12.58
- Forward P/E
- 56.17
- Beta
- 1.16
- Short ratio
- 7.68
- Inst. own
- 86.16%
- Dividend
- 6.60
- Ex-div date
- Sep 17, 2023
- 50-d avg
- 18.72
- 200-d avg
- 22.71
- 1y target
- 16.50
MAX chart
Events in this range
- Feb 7, 2023Dividend: 1.64
- Aug 7, 2023Earnings: 2.77; estimate 1.44; surprise 92.36%
- Nov 6, 2023Earnings: 2.12; estimate 1.02; surprise 107.84%
- Jun 5, 2024Downgrade: DA Davidson · Neutral → Underperform
- Aug 5, 2024Earnings: 0.92; estimate 0.36; surprise 155.56%
- Nov 4, 2024Earnings: 0.35; estimate -0.15; surprise 333.33%
- Nov 5, 2024Rating: DA Davidson · Underperform → Neutral
Signals (110)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Aug 1, 2026 | 3 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 1, 2026 | 6 months ago |
| MACD: Buy Signal | Nov 1, 2024 | 2 years ago |
| RSI: Oversold | Feb 1, 2024 | 2 years ago |
| SMA: Bearish | Mar 1, 2022 | 4 years ago |
| MACD: Sell Signal | Oct 1, 2021 | 5 years ago |
| SMA: Bearish | Aug 1, 2021 | 5 years ago |
| RSI: Overbought | May 1, 2021 | 5 years ago |
| RSI: Overbought | Feb 1, 2021 | 5 years ago |
| MACD: Buy Signal | Jul 1, 2020 | 6 years ago |
| SMA: Bullish | Jun 1, 2020 | 6 years ago |
| SMA: Bullish | May 1, 2020 | 6 years ago |
| SMA: Bearish | Aug 1, 2019 | 7 years ago |
| MACD: Sell Signal | Jan 1, 2019 | 7 years ago |
| SMA: Bearish | Nov 1, 2018 | 8 years ago |
| RSI: Overbought | Aug 1, 2017 | 9 years ago |
| SMA: Bullish | Jul 1, 2017 | 9 years ago |
| SMA: Bearish | Jun 1, 2017 | 9 years ago |
| RSI: Overbought | Jan 1, 2017 | 9 years ago |
Newest 20 of 110.
Financial health
Altman Z-Score
3.85 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 5
Valuation
P/E -6.3×
FY 2016 5y median 9.0× FY 2025
P/S 0.3×
FY 2016 5y median 0.7× FY 2025
P/B 0.6×
FY 2016 5y median 3.6× FY 2025
P/FCF 93.9×
FY 2016 5y median 11.3× FY 2025
EV/EBITDA 5.2×
FY 2016 5y median 6.3× FY 2025
EV/Sales 0.1×
FY 2016 5y median 0.6× FY 2025
FCF Yield 1.1%
FY 2016 5y median 8.8% FY 2025
Profitability
Gross Margin 71.3%
FY 2016 5y median 72.4% FY 2025
Operating Margin -3.7%
FY 2016 5y median 11.6% FY 2025
Net Margin -4.8%
FY 2016 5y median 9.0% FY 2025
ROE -9.4%
FY 2016 5y median 49.3% FY 2025
ROIC -6.5%
FY 2016 5y median 43.7% FY 2025
ROA -7.3%
FY 2016 5y median 32.1% FY 2025
Growth (YoY)
Revenue -36.0%
FY 2016 FY 2025
Operating Income -593.8%
FY 2016 FY 2025
EPS (diluted) -994.7%
FY 2016 FY 2025
Free Cash Flow -92.7%
FY 2016 FY 2025
Financial Health
Current Ratio 4.7×
FY 2016 5y median 2.4× FY 2025
Quick Ratio 4.2×
FY 2016 5y median 1.8× FY 2025
Debt / Equity 0.1×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA -8.4×
FY 2016 5y median -0.5× FY 2025
Interest Coverage 0.0×
FY 2016 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.2%
FY 2016 5y median 2.6% FY 2025
Payout Ratio -1.0%
FY 2016 5y median 38.9% FY 2025
Annual · latest fiscal year ends 2025-12-31
